EU pharma legislation – impact on SMEs
In April 2023, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it can meet…
The Life Sciences Acceleration Alliance e.V. (LSAA) is a coalition of venture capitalists, corporate leaders, and subject matter experts dedicated to strengthening life sciences innovation and development in the EU seeking to ensure that policy in Europe evolves towards medical discovery, commercialisation and the benefit to patients.
There is an opportunity for proactive policies that could better commercialise innovation and yield economic and health benefits
Here you can change your privacy preferences.